ENDPOINTS

FDA approves Alnylam’s Amvuttra in ATTR-CM, kicking off competition with Pfizer, BridgeBio

Mar 20, 2025 - 23:10
 0
FDA approves Alnylam’s Amvuttra in ATTR-CM, kicking off competition with Pfizer, BridgeBio
Read More

Tags:

Previous Article

Evidence Grows That Dark Energy Changes Over Time

Next Article

Cylinder Acquires AI-powered Stool Imaging Platform Dieta Health

Related Posts

Sorriso Pharmaceuticals outlines Phase 1b ulcerative colitis data for oral antibody

Sorriso Pharmaceuticals outlines Phase 1b ulcerative co...

Feb 27, 2025  0

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai a...

Feb 28, 2025  0

BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen

BridgeBio oncology spinout to go public via combination...

Feb 28, 2025  0